This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Dr. Padmanee Sharma of MD Anderson discusses what breakthroughs and advances might lie ahead for the field of cancer immunotherapy in 2020.
Discover antibody-based imaging strategies that help doctors visualize patients’ tumors and immune cells in real-time via PET scans.
Discover the full potential of genome-based medicine with genomic and genetic testing for cancer risk and tumor assessment.
Discover how doctors and patients can recognize and safely manage an overstimulated or misdirected immune response.
Discover the microscopic organisms that inhabit our bodies and new microbiome-based treatment strategies in the clinic.
Dr. Michel Sadelain of Memorial Sloan Kettering highlights a revolutionary new treatment approach—CAR T cell immunotherapy—that he helped pioneer.
Brendan Connors and his oncologist Dr. Michael Postow of Memorial Sloan Kettering discuss the importance of communication between patient and doctor throughout immunotherapy treatment.
Dr. Patrick Hwu of the MD Anderson highlights the promise and potential of combination immunotherapies and how biomarkers can be used to guide these strategies.
Dr. Elizabeth M. Jaffee of Johns Hopkins University discusses cancer immunotherapy’s ongoing efforts to overcome the challenges ahead and enable immunotherapy to benefit even more people with cancer.
Caregivers Casey Zmudzinski and Benny Juarez, and cancer veteran Kristin Kleinhofer, discuss how they advocate for the best care possible for their loved ones.
Dr. Matthew Hellmann of Memorial Sloan Kettering Cancer Center discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.
Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.
Two cancer patients—Stephen Estrada and Mary Elizabeth Williams—discuss how they regained control after their cancer diagnosis
Dr. Gavin Dunn of Washington University in St. Louis discusses how cancer vaccines are capable of educating patients’ immune systems and have the potential to improve the immune system’s ability to target and eliminate cancer.
Dr. Kunle Odunsi of the Roswell Park Comprehensive Cancer Institute discusses how biomarkers are used to help patients today as well as how we’re working to harness the full potential of biomarkers moving forward.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
How the video game live stream fundraiser “Prepare to Destroy Cancer” is supporting cancer immunotherapy research
How the microbiome influences the fight against cancer and what Dr. Sonnenberg hopes to accomplish during the next five years as a CRI Lloyd J. Old STAR.